Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Ligand and Lilly enter drug discovery and development alliance for metabolic drugs

Oct. 23, 1997

Endocrinologic and Metabolic Drugs Advisory Committee meets in late November

Oct. 22, 1997

Mechanism of cytoprotective effects of bimoclomol

Oct. 22, 1997

Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor

Oct. 22, 1997

Romozin now available in U.K.

Oct. 22, 1997

New estrogen receptor ligand reported by Glaxo Wellcome

Oct. 22, 1997

ArQule and Acacia to develop novel drug candidates

Oct. 22, 1997

Megestrol + ibuprofen for cancer cachexia

Oct. 21, 1997

First launch for Yamanouchi bisphosphonate

Oct. 21, 1997

FDA approves Follistim for IVF and ovulation induction

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...